Kit and detection method for detecting common pathogenic bacteria of otitis media based on multi-enzyme constant-temperature rapid nucleic acid amplification technology
By combining multi-enzyme isothermal rapid nucleic acid amplification (MIRA) technology with specific primers and probes and a dual detection mode, the problems of long detection time and insufficient specificity of pathogens causing otitis media are solved, realizing rapid and convenient triple simultaneous detection, which is suitable for primary healthcare and point-of-care testing.
Patent Information
- Application Number
- CN202610423730.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-01
- Publication Date
- 2026-06-23
AI Technical Summary
Existing technologies for detecting pathogens causing otitis media are time-consuming, complex to operate, and lack specificity and resistance to interference, making it difficult to meet the rapid diagnostic needs of primary healthcare institutions and bedside testing.
Using multi-enzyme isothermal rapid nucleic acid amplification (MIRA) technology, specific primers and probes are designed and combined with dual detection modes of fluorescence and colloidal gold to achieve triple simultaneous detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. This simplifies the operation process and is suitable for ordinary isothermal equipment.
It achieves rapid, efficient, and convenient triple simultaneous detection, shortens detection time, and improves the specificity and sensitivity of the test. It is suitable for primary healthcare and point-of-care testing, and avoids the problem of drug resistance caused by indiscriminate drug use.